180
Participants
Start Date
September 15, 2020
Primary Completion Date
January 1, 2024
Study Completion Date
August 5, 2024
Oral co-amoxiclav or oral dicloxacillin only
High dose oral treatment followed by standard dose oral treatment
IV ceftriaxon followed by oral co-amoxiclav or oral dicloxacillin
IV treatment followed by standard dose oral treatment
Copenhagen University Hospital, Rigshospitalet, Copenhagen
Collaborators (1)
The research foundation of Copenhagen University Hospital, Rigshospitalet
UNKNOWN
Copenhagen Health Science Partners
UNKNOWN
Innovation Fund Denmark
INDIV
Rigshospitalet, Denmark
OTHER